Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric protein
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric protein
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 8, Issue 1, Pages e000233
Publisher
BMJ
Online
2020-06-09
DOI
10.1136/jitc-2019-000233
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MICA immune complex formed with alpha 3 domain-specific antibody activates human NK cells in a Fc-dependent manner
- (2019) Changchun Du et al. Journal for ImmunoTherapy of Cancer
- Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
- (2018) Lucas Ferrari de Andrade et al. SCIENCE
- MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma
- (2018) Alessandra Zingoni et al. Frontiers in Immunology
- Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance
- (2017) Alessandra Zingoni et al. Frontiers in Immunology
- Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapy
- (2017) Jingyu Zhang et al. Science Advances
- NK Cells Restrain Spontaneous Antitumor CD8+T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells
- (2016) Ximena L. Raffo Iraolagoitia et al. JOURNAL OF IMMUNOLOGY
- Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells
- (2015) Alessandra Zingoni et al. JOURNAL OF IMMUNOLOGY
- Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients
- (2015) CAROLINA HAGER RIBEIRO et al. ONCOLOGY REPORTS
- NKG2D Ligands in Tumor Immunity: Two Sides of a Coin
- (2015) Jinyu Zhang et al. Frontiers in Immunology
- MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
- (2015) Hanbyoul Cho et al. BMC CANCER
- Defective Infiltration of Natural Killer Cells in MICA/B-Positive Renal Cell Carcinoma Involves β2-Integrin-Mediated Interaction
- (2015) Giuseppe Sconocchia et al. NEOPLASIA
- Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells
- (2014) B. Wang et al. CANCER RESEARCH
- Intracellular Retention of the NKG2D Ligand MHC Class I Chain-Related Gene A in Human Melanomas Confers Immune Privilege and Prevents NK Cell-Mediated Cytotoxicity
- (2014) M. B. Fuertes et al. JOURNAL OF IMMUNOLOGY
- Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions
- (2013) Raúl Germán Spallanzani et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell-Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3
- (2013) C. Fionda et al. JOURNAL OF IMMUNOLOGY
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in Exosomes
- (2010) O. Ashiru et al. CANCER RESEARCH
- Targets of Protective Tumor Immunity
- (2009) Glenn Dranoff Annals of the New York Academy of Sciences
- MB49 Murine Urothelial Carcinoma: Molecular and Phenotypic Comparison to Human Cell Lines as a Model of the Direct Tumor Response to Bacillus Calmette-Guerin
- (2009) Fanghong Chen et al. JOURNAL OF UROLOGY
- Tumor-Associated MICA Is Shed by ADAM Proteases
- (2008) I. Waldhauer et al. CANCER RESEARCH
- MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma
- (2008) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started